India Stakes in Global Pandemic Agreement Negotiations
Source:The Hindu ↗
हे का महत्त्वाचे आहे
Understanding India's negotiating stance at multilateral health forums like the WHO is essential for analyzing how international law intersects with India's domestic pharmaceutical capabilities and global health equity goals.
सारांश
The article discusses India's strategic stakes in the World Health Organization's (WHO) Global Pandemic Agreement negotiations. It highlights the tension between global health equity, pathogen sharing, intellectual property rights, and the protection of India's domestic pharmaceutical and generic manufacturing ecosystem.
मुख्य मुद्दे
- India holds major stakes in the ongoing negotiations for the WHO Global Pandemic Agreement, balancing global health security with domestic industrial interests.
- Key contentious issues include equitable access to pathogen genetic sequence data (PABS), benefit-sharing, and technology/know-how transfer for vaccines and therapeutics.
- Intellectual Property Rights (IPR) flexibilities and protection of India's robust generic pharmaceutical manufacturing capacity are critical negotiating priorities.
- A balanced agreement must avoid imposing disproportionate burdens on developing nations while ensuring rapid response capabilities against future health emergencies.
महत्त्वाच्या संज्ञा
Global Pandemic Agreement
A legally binding instrument currently negotiated under the World Health Organization to strengthen global prevention, preparedness, and response to future pandemics, focusing on equity and access to countermeasures.
UPSC context
GS Paper II (International Relations / Global Health Governance): Tests understanding of multilateral treaties, public health equity, and India's strategic stakes.
TRIPS Agreement
A WTO international agreement administering intellectual property standards, key to debates over compulsory licensing and technology transfer for generic drug manufacturing during public health crises.
UPSC context
GS Paper II & III (International Relations / Economy): Tests knowledge of international trade law, IP rights, and India's generic pharmaceutical sector.
World Health Organization
The specialized agency of the United Nations responsible for international public health, coordinating responses to health emergencies and setting global norms.
UPSC context
GS Paper II (International Organizations): Tests role of UN specialized agencies in global health governance and multilateral diplomacy.
पूर्वपरीक्षा सापळा
The Global Pandemic Agreement completely replaces WTO TRIPS provisions for all emergency medical countermeasures.
Aspirants often assume the WHO Global Pandemic Agreement bypasses WTO TRIPS, whereas India explicitly insists on operationalising TRIPS flexibilities within the treaty.
संबंधित स्थिर संकल्पना
What are the key flexibilities available under the WTO TRIPS Agreement for public health?
- Compulsory Licensing:: Permits governments to issue compulsory licenses for domestic production without patent holder consent during national emergencies.
- Parallel Importing:: Allows importation of generic pharmaceutical products manufactured under compulsory license from countries with insufficient domestic manufacturing capacity.
- LDC Exemptions:: Least developed countries (LDCs) enjoy extended transition periods exempting them from pharmaceutical patent enforcement obligations.
आंतर-विषय नमुने
TRIPS Flexibilities and Global Health Equity
India's defense of TRIPS flexibilities in the Pandemic Agreement mirrors its historic stance at WTO Doha declarations and climate technology transfers.
Pathogen Access and Critical Mineral Nationalism
Pathogen access debates parallel critical mineral resource nationalism, where developing nations demand fair returns for raw data and materials supplied to industrialised countries.
WHO Pandemic Agreement + TRIPS flexibilities + PABS system likely to appear as a multi-statement assertion question in Prelims.
संबंधित PYQ · 1
संबंधित PYQ · 1
- 2020MainsGS2
Critically examine the role of WHO in providing global health security during the Covid-19 pandemic.
